Oenothera Biennis.
Research-backed compound with potential health benefits. Plant native to North America. Seeds pressed for GLA-rich oil.
Reviewed March 2026
- Category
- Compound
What Oenothera Biennis is, and what it does.
- Does it work
- Reasonable for skin conditions and PMS. Manage expectations.
- How much to take
- Start with 500mg a day and work up toward 2,000mg. That band is where the preformed GLA in the oil earns its keep. Take it with a meal that has some fat in it.
- Time to feel it
- Give it eight to twelve weeks of daily use. Fatty acids have to work their way into tissue lipids first, so this is a slow build rather than a same-week change.
- The first dose
- Day one is quiet. The oil digests like any other fat and starts feeding the GLA pathway straight away, and that shows up in tissue lipids over the weeks after.
- With regular use
- Fatty acid supplementation takes months to show full effects.
- How well tolerated
- Usually well tolerated; mild stomach upset or headache turn up occasionally. Check with a clinician if you take blood thinning medicine or anything acting on the nervous system.
- How it feels
- Not much of a sensation. People tend to notice it in how skin looks and feels after a couple of months rather than as anything on the day.
- The overlooked benefit
- The linoleic acid does a job the GLA cannot: it builds the ceramide that anchors the skin barrier. That fatty acid is about seventy percent of the oil.
500 to 2,000mg a day is where Oenothera Biennis works.
Source: Morse & Clough, J Nutr Med, 2006; evening primrose oil meta-analyses
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Oenothera Biennis is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- raising dihomo-gamma-linolenic acid in blood lipidsRandomised trial
- skin barrier support and skin hydrationRandomised trial
- comfort across the monthly cycleMeta-analysis
- temperature comfort through the midlife hormonal shiftRandomised trial
- series-1 prostaglandin production from preformed GLANarrative review
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Evening primrose seed oil is one of the few dietary sources of gamma-linolenic acid, usually around 8 to 10 percent of the oil. GLA is the fraction the oil is standardised on.
GLA elongates to dihomo-gamma-linolenic acid, which can either make series-1 eicosanoids or be desaturated onward to arachidonic acid. Co-dosing EPA restrains that onward step and competes at cyclooxygenase, which is why GLA oils are conventionally paired with marine omega-3.
Combined GLA and marine omega-3 blends exist because the fish oil keeps accumulated DGLA from being converted onward to arachidonate. That is the usual way GLA is presented.
Delta-6 desaturase activity, the step upstream of GLA, depends on adequate pyridoxine alongside zinc and magnesium. Formulators pair B6 with evening primrose oil on that basis.
Zinc is required for normal delta-6 desaturase function in the essential fatty acid pathway. Low zinc slows the conversion that GLA supplementation is meant to bypass.
Magnesium is one of the cofactors for the desaturase and elongase steps in polyunsaturated fatty acid handling. It is commonly co-formulated with GLA oils for that reason.
Polyunsaturated oils oxidise readily, and tocopherol is the chain-breaking antioxidant that interrupts lipid peroxidation. Evening primrose oil capsules almost always carry added vitamin E for stability.
Borage seed oil carries roughly two to three times the GLA fraction of evening primrose oil. Stacking the two adds GLA from two botanical sources.
Black currant seed oil supplies GLA alongside stearidonic acid, which sits past the delta-6 step on the omega-3 side. Combined with evening primrose it broadens the fatty acid profile rather than duplicating it.
Evening primrose seed oil is roughly seventy percent linoleic acid and under ten percent gamma-linolenic acid, so the oil is mostly the precursor and only partly the product. Delta-6 desaturase converts linoleic acid into GLA and is the rate-limiting step of the sequence. Anyone reading a GLA percentage on a label is reading the small fraction, not the bulk of the oil.
Alpha-linolenic acid from flax and linoleic acid from evening primrose compete for the same delta-6 desaturase enzyme, since the omega-3 and omega-6 series share the whole desaturation and elongation chain. Loading one shifts flux away from the other. That is a reason to think about the ratio rather than a reason to avoid the pairing.
Preformed EPA and DHA bypass the desaturase bottleneck entirely, but they also compete with dihomo-gamma-linolenic acid for cyclooxygenase and for incorporation into membrane phospholipids. The result is a shift in which eicosanoid series predominates. Products that combine the two oils are managing that balance deliberately.
DHA occupies the same membrane phospholipid positions that omega-6 derived fatty acids would take, and high DHA intake reduces arachidonic acid content of those membranes. Evening primrose oil pushes in the opposite direction along the omega-6 arm. The interaction is one of proportion, not of blocking.
A polyunsaturated seed oil with several double bonds per molecule oxidises readily once pressed, and mixed tocopherols are the standard chain-breaking antioxidant added to slow that. Almost every softgel of this oil carries some. The role is protecting the oil, which is worth naming plainly rather than presenting as a physiological partnership.
Tocotrienols are chain-breaking antioxidants in the same vitamin E family and are used in oil systems for the same stabilising purpose as tocopherols. They are less common in this application because of cost. The function is shelf stability.
Ascorbate reduces the tocopheroxyl radical back to tocopherol at the aqueous and lipid interface, which is what keeps a lipid-phase antioxidant system regenerating rather than being consumed once. In a polyunsaturated oil that recycling matters. This is redox chemistry, and the endpoint is oxidation of the oil.
Rosemary extract standardised to carnosic acid and rosmarinic acid is a widely used natural antioxidant in polyunsaturated oils, often paired with tocopherols because the two act at different points of the oxidation chain. It appears in seed oil softgels for that reason. This is a stability role, not an added ingredient effect.
Astaxanthin is a lipid-soluble carotenoid that sits in the same oil phase and in the same membrane region as the fatty acids delivered by this oil. Co-formulation is a solubility convenience. No combination study exists for the pair.
Biotin is the cofactor for acetyl-CoA carboxylase, the entry point of fatty acid synthesis and elongation chemistry that also handles dietary fatty acids. It is listed alongside zinc and B6 in the classic desaturase cofactor set. The link is general fatty acid metabolism rather than anything specific to GLA.
Desaturase reactions consume reducing equivalents supplied through NADH and the cytochrome b5 system, and NAD derives from niacin. Adequate niacin is therefore part of the background required for endogenous conversion of linoleic acid to GLA. Supplying preformed GLA reduces how much that conversion matters.
The oil arrives as triglycerides that pancreatic lipase must hydrolyse before the fatty acids can be absorbed. Where fat digestion is limited, less of the GLA fraction is released. A digestive lipase addresses that step directly.
Long-chain triglycerides depend on bile salt micelles for emulsification and enterocyte uptake, unlike medium-chain fats. Reduced bile output is therefore a mechanistic reason for lower absorption of this oil. Taking it with a meal containing fat serves the same end.
Lecithin emulsifies seed oils in liquid and topical formats and helps keep an emulsion from separating. In a softgel it plays no absorption role since the oil is already a lipid. The function is physical.
Evening primrose oil and collagen peptides appear together in skin-directed products, one supplying fatty acids that make up part of the skin barrier lipid pool and the other supplying amino acids used in connective tissue. The mechanisms are separate. No trial has tested this specific combination.
Hyaluronic acid binds water in the dermis while the fatty acids from this oil contribute to barrier lipids that slow water loss outward. The two act on different sides of the same hydration question. This is a product design pairing rather than a studied one.
The stratum corneum barrier is built from ceramides, cholesterol and free fatty acids in a defined ratio, and linoleic acid specifically is required for the acylceramide that holds the lamellar structure together. Evening primrose oil is a linoleic-rich source. Supplying both parts of the same lipid matrix is the rationale.
Both are routine components of women's midlife formulas and are combined for that reason rather than for any shared mechanism. Their chemistry does not overlap. Read the pairing as formulation convention.
Nothing specific on file for Oenothera Biennis. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Oenothera Biennis actually does.
Evening primrose seed oil is dominated by linoleic acid at roughly seventy percent, with gamma-linolenic acid typically between seven and ten percent and the balance oleic and palmitic acids.
Gamma-linolenic acid bypasses delta-6 desaturase, the rate-limiting enzyme that would otherwise be needed to convert dietary linoleic acid into GLA, which is the whole point of supplying preformed GLA.
GLA is elongated to dihomo-gamma-linolenic acid, which is the direct precursor of series-1 prostaglandins and can also be desaturated onward to arachidonic acid.
Delta-6 desaturase activity depends on zinc, magnesium and vitamin B6 as part of the enzyme system, which is why those nutrients are routinely listed alongside GLA oils.
Where Oenothera Biennis comes from.
Small seeds from a roadside wildflower get pressed for their oil. Some makers press cold and leave the oil unrefined, others extract with solvent for a higher yield and then clean the oil up, and both routes end at a capsule. Because the oil goes off easily, an antioxidant is added and the freshness numbers on the certificate are the thing to ask for.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
A biennial that flowers in its second year and sets small seed capsules. Grown as a contract crop in Canada, China, central Europe and the United Kingdom. Seed GLA content varies with cultivar and growing season, which is why lots are assayed rather than assumed.
Seed is cleaned of chaff and dried to a target moisture before pressing, since excess moisture drives hydrolytic rancidity in the finished oil.
Screw pressing under controlled temperature gives an unrefined oil with lower yield. Hexane extraction of the press cake recovers the remaining oil at higher yield and requires solvent removal afterwards. Supercritical CO2 is a third route that avoids organic solvent.
Where a neutral oil is required, the crude oil is degummed, neutralised, bleached with clay and deodorised under vacuum. Unrefined product skips this and keeps more of the native minor components.
Gas chromatography sets the GLA percentage and the oil is blended to specification. Mixed tocopherols or rosemary extract are added, and peroxide and anisidine values are checked as freshness measures.
Filled into softgels under nitrogen, bottled in dark glass, or blended into a cosmetic base.
Getting Oenothera Biennis from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Pooled randomised trials found evening primrose oil shifted blood lipid measures, with the clearest change in total cholesterol.Meta-analysis. Khorshidi et al., 2020 (Phytotherapy Research). PMID 32441049 ↗
- Across pooled trials, evening primrose oil reduced cyclical breast discomfort scores more than placebo.Meta-analysis. Ahmad Adni et al., 2021 (International Journal of Environmental Research and Public Health). PMID 34200727 ↗
- A review of clinical trials found evening primrose oil lowered several circulating inflammatory markers, with results varying by population and dose.Systematic review. Sharifi et al., 2024 (BMC Complementary Medicine and Therapies). PMID 38360611 ↗
- Evening primrose oil supplementation changed measured skin condition parameters compared with control over the study period.Randomised trial. Kaźmierska et al., 2022 (Nutrients). PMID 35889936 ↗
- Oenothera biennis oil was evaluated in vitro and in ovo as an alternative preservative for oil-based products, with antioxidant and antimicrobial behaviour characterised.In vitro study. Fecker R et al., 2025 (Foods). PMID 39856999 ↗
- Oral evening primrose LEAF extract was reported to improve memory measures in a transgenic mouse model; the leaf extract is a different material from the seed oil that most products contain.Animal study. Kim Y et al., 2026 (Food science and biotechnology). PMID 42077786 ↗
These are the studies our verdict leans on, chosen from the 196 we read for Oenothera Biennis. The full linked list is below.
Problems people have reported.
Read this carefully. These are 503 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Oenothera Biennis is, not how risky it is. A report is not proof Oenothera Biennis caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.